NCT01401543View on ClinicalTrials.gov

A Bioavailability Study of LY2452473 and Tadalafil

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Erectile Dysfunction
Interventions
DRUG

LY2452473

Administered orally

DRUG

Tadalafil

Administered orally

DRUG

LY900010

Administered orally

Trial Locations (1)

53704

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madison

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01401543 - A Bioavailability Study of LY2452473 and Tadalafil | Biotech Hunter | Biotech Hunter